Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
US8853379B2 · kind B2 · utility
8Cited by
1References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 19, 2011 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | Jun 14, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.